StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research note released on Wednesday morning. The brokerage issued a hold rating on the stock.
TherapeuticsMD Stock Up 1.3 %
Shares of TXMD stock opened at $1.60 on Wednesday. The firm’s 50-day moving average is $1.70 and its two-hundred day moving average is $1.85. TherapeuticsMD has a 12 month low of $1.43 and a 12 month high of $3.07.
TherapeuticsMD (NASDAQ:TXMD – Get Free Report) last released its quarterly earnings results on Monday, August 12th. The company reported ($0.09) EPS for the quarter. The firm had revenue of $0.23 million for the quarter.
Institutional Trading of TherapeuticsMD
About TherapeuticsMD
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Featured Articles
- Five stocks we like better than TherapeuticsMD
- What Are the U.K. Market Holidays? How to Invest and Trade
- Survey Reveals: America’s Most Coveted Businesses in 2024
- 3 Monster Growth Stocks to Buy Now
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- 3 Best Fintech Stocks for a Portfolio Boost
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.